Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Copaxone

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Glatiramer acetate (GA; copolymer-1, Copaxone) suppresses the induction of experimental autoimmune encephalomyelitis and reduces… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
CD4(+)CD25(high) T regulatory (Tr) cells, representing high IL-2 receptor alpha chain expressing cells, have been shown to… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Glatiramer acetate (GA; Copaxone) is a random copolymer of glutamic acid, lysine, alanine, and tyrosine that is used… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To compare the clinical efficacy, as expressed by relapse rate and disability accumulation, and safety profile of… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Humoral and cellular immune responses were followed in multiple sclerosis patients treated with Copolymer 1 (Cop1, glatiramer… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Copolymer-1 (Copaxone or COP) inhibits experimental allergic encephalomyelitis and has beneficial effects in multiple sclerosis… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
&NA; The purpose of this study was to evaluate psychological, biophysical, and sociodemographic variables as predictors of… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
We examined the effect of glatiramer acetate, a random copolymer of alanine, lysine, glutamic acid, and tyrosine, on antigen… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
When 251 relapsing-remitting patients with multiple sclerosis were randomized to receive daily subcutaneous injections of… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The synthetic polypeptide copolymer-1 (Cop-1; Copaxone; Glatiramer Acetate) has been recently approved as an effective treatment… Expand
Is this relevant?